Literature DB >> 31502477

Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies.

Chin Liang Lee1, Sanggeetha Veeramani1, Aidin Molouki2, Swee Hua Erin Lim1,3, Warren Thomas1, Suet Lin Chia4,5, Khatijah Yusoff4,5.   

Abstract

Colorectal cancer (CRC) is one of the most common malignancies. In recent decades, early diagnosis and conventional therapies have resulted in a significant reduction in mortality. However, late stage metastatic disease still has very limited effective treatment options. There is a growing interest in using viruses to help target therapies to tumour sites. In recent years the evolution of immunotherapy has emphasised the importance of directing the immune system to eliminate tumour cells; we aim to give a state-of-the-art over-view of the diverse viruses that have been investigated as potential oncolytic agents for the treatment of CRC.

Entities:  

Keywords:  Recombinant oncolytic virus; apoptosis; colorectal cancer; virotherapy

Mesh:

Year:  2019        PMID: 31502477     DOI: 10.1080/07357907.2019.1660887

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  3 in total

1.  Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells.

Authors:  Weiyan Zou; Jie Zhao; Yi Li; Zishu Wang; Haiqin Yan; Yudong Liu; Meiqun Sun; Jialu Zhuang; Junbin Wang
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

Review 2.  Immunogenic cell death in colon cancer prevention and therapy.

Authors:  Hang Ruan; Brian J Leibowitz; Lin Zhang; Jian Yu
Journal:  Mol Carcinog       Date:  2020-03-25       Impact factor: 4.784

3.  Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model.

Authors:  Fanrui Meng; Yukai Cao; Han Su; Tianyan Liu; Limin Tian; Yu Zhang; Jiarui Yang; Wei Xiao; Deshan Li
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.